Compare Stocks → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:CLSN Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCLSNImunon$2.22$1.80▼$15.75$13.91M2.27150,471 shs711 shs10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCLSNImunon0.00%0.00%0.00%0.00%0.00%$25,000 into $109,616 in two months? (Ad)Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…Go here to watch the most recent trading workshop video at no charge.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCLSNImunonN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCLSNImunonN/AN/AN/AN/ASales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCLSNImunon$500K0.00N/AN/A$9.66 per share0.00Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCLSNImunon-$20.77MN/A0.00N/AN/A-5,229.80%-50.18%-36.94%N/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCLSNImunonN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCLSNImunon0.136.526.52OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCLSNImunon12.97%Insider OwnershipCompanyInsider OwnershipCLSNImunon4.66%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableCLSNImunon277.10 million6.77 millionOptionablePAGE, OLEE, STHR, and CLSN HeadlinesSourceHeadlineImunon Inc IMNNmorningstar.com - March 10 at 7:09 PMCLSN.L Regulatory Newslse.co.uk - May 22 at 5:10 PMHC Wainwright & Co. Reiterates Buy on Imunon, Maintains $12 ... - Benzinganews.google.com - May 12 at 3:46 PMShakira rocks a purple bikini as she joins Lewis Hamilton on a boat ride in Miami - Yahoo Movies Canadanews.google.com - May 12 at 10:46 AMIMUNON Reports First Quarter 2023 Financial Results and Provides Business Update - Yahoo Financenews.google.com - May 12 at 10:46 AMImunon GAAP EPS of -$0.68 beats by $0.01 - Seeking Alphanews.google.com - May 11 at 6:46 PMImunon earnings missed by $0.06, revenue was in line with ... - Investing.comnews.google.com - May 11 at 6:46 PMImunon: Q1 Earnings Insights - Imunon (NASDAQ:IMNN) - Benzinganews.google.com - May 11 at 6:46 PMIMUNON Reports First Quarter 2023 Financial Results and Provides ... - GlobeNewswirenews.google.com - May 11 at 6:46 PMIMUNON to Hold First Quarter 2 - GuruFocus.comnews.google.com - May 6 at 7:36 AMIMUNON to Hold First Quarter 2023 Financial Results and Business ... - Marketscreener.comnews.google.com - May 5 at 4:33 PMIMUNON Presents Poster at the American Association for Cancer ... - GlobeNewswirenews.google.com - April 19 at 9:58 AMIMNN: PLACCINE Technology Presented at Vaccine Technology Summit… - Yahoo Financenews.google.com - April 14 at 7:34 AMImunon Full Year 2022 Earnings: EPS Misses Expectations - Yahoo Eurosport UKnews.google.com - April 2 at 7:29 AMImunon Full Year 2022 Earnings: EPS Misses Expectations - Yahoo Financenews.google.com - April 1 at 1:01 PMIMUNON Reports 2022 Financial Results and Provides Business Update - Yahoo Financenews.google.com - April 1 at 1:01 PMImunon, Inc. - Common Stock Earnings Perspective: Return On ... - Benzinganews.google.com - March 31 at 4:57 PMForm 10-K Imunon, Inc. For: Dec 31 - StreetInsider.comnews.google.com - March 30 at 5:29 PMImunon earnings missed by $0.62, revenue fell short of estimates By ... - Investing.comnews.google.com - March 30 at 12:28 PMIMUNON Reports 2022 Financial Results and Provides Business ... - GlobeNewswirenews.google.com - March 30 at 12:28 PMImunon Q4 2022 Earnings Preview - Seeking Alphanews.google.com - March 29 at 6:31 PMImunon, Inc. - Common Stock Earnings Preview - Imunon (NASDAQ ... - Benzinganews.google.com - March 29 at 1:30 PMASLAN Pharma A Promising Investment Opportunity in Biotechnology - Best Stocksnews.google.com - March 27 at 12:33 PMIMUNON to Hold Fourth Quarter - GuruFocus.comnews.google.com - March 24 at 1:29 AMTop Headlines3 Value Stocks Too Small For Buffett’s PortfolioMarch 28, 2024 12:16 PMView 3 Value Stocks Too Small For Buffett’s PortfolioFoot Locker Builds Up Another Head of Steam; Gains ImminentMarch 28, 2024 10:58 AMView Foot Locker Builds Up Another Head of Steam; Gains Imminent5 Stocks in the Current Bull Market with Upside to ComeApril 5, 2024 10:14 AMView 5 Stocks in the Current Bull Market with Upside to Come5 Top-Rated Dividend Stocks With Double-Digit UpsideMarch 25, 2024 11:19 AMView 5 Top-Rated Dividend Stocks With Double-Digit Upside2 Earnings Dumpers Worth a Second LookMarch 25, 2024 6:05 AMView 2 Earnings Dumpers Worth a Second LookAll Headlines Company DescriptionsImunonNASDAQ:CLSNCelsion Corporation, a clinical stage biotechnology company, focuses on the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies. Its product pipeline includes GEN-1, a DNA-based immunotherapy for the localized treatment of ovarian cancer; and ThermoDox, a proprietary heat-activated liposomal encapsulation of doxorubicin, which is in development stage for various cancer indications. The company also has two feasibility stage platform technologies for the development of nucleic acid-based immunotherapies, vaccines, and other anti-cancer DNA or RNA therapies. Celsion Corporation was founded in 1982 and is based in Lawrenceville, New Jersey. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
